Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
December 8, 2025Blood

Impact of conditioning intensity on outcomes after unrelated donor hematopoietic cell transplantation using posttransplant cyclophosphamide-based GVHD prophylaxis

View Full Paper
Ask AI
Bookmark
Share

Authors

MSMoazzam ShahzadAKAmir KasaeianMHMehdi Hamadani

Discussion

Loading...

Member takes

Overview

Retrospective cohort study shows conditioning intensity affects transplant outcomes in unrelated donor hematopoietic cell transplantation, suggesting careful treatment planning.

Key Points

  • Conditioning intensity in unrelated donor hematopoietic cell transplantation impacted relapse and disease-free survival outcomes, elevating care concerns.
  • Overall survival and non-relapse mortality remained unaffected, showing complexity in patient response to treatment.
  • Cox proportional hazards models identified significant associations with conditioning type and acute/chronic GVHD outcomes.
  • Individualized conditioning plans may be essential due to age and comorbidity influence on transplant results.

Cite This Study

Shahzad et al. (2025) studied this question.

synapsesocial.com/papers/69362f7d4fa91c937236e50bhttps://doi.org/10.1182/blood-2025-505
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Outcomes after bone marrow versus peripheral blood mismatched unrelated donor hematopoietic cell transplantation using posttransplant cyclophosphamide-based GVHD prophylaxis2025
  2. 2Factors associated with acute and chronic graft-versus-host disease after unrelated donor hematopoietic cell transplantation using posttransplant cyclophosphamide-based GVHD prophylaxis2025
  3. 3Phase II Study of post transplant cyclophosphamide-based graft versus host disease prophylaxis after HLA-mismatched unrelated donor transplantation and reduced intensity conditioning: Results from the NMDP-sponsored access expansion Study2025
  4. 4Post-transplant cyclophosphamide based GVHD prophylaxis in HLA-matched related and unrelated donor hematopoietic cell transplantation in adults with hematologic malignancies undergoing myeloablative conditioning: A CIBMTR analysis of 8,272 participants2025
  5. 5Post-transplant cyclophosphamide (PTCy) versus other graft-versus-host disease prophylaxis strategies in reduced intensity allogeneic stem cell transplantation from related and matched unrelated donors in patients with acute myeloid leukemia and myelodysplastic syndromes: A study from the french society of bone marrow transplantation (SFGM-TC) registry2025